- December 19, 2023
- Post by Julie Bick, Ph.D.
Pharmacogenomics, the study of how an individual’s genetic makeup influences drug responses, has ushered in a new era of personalized medicine. One of the areas most impacted by pharmacogenomics is within the field of clinical trials. Traditionally, clinical trials followed a one-size-fits-all approach, treating all patients as a homogeneous group. However, with the integration of pharmacogenomics, clinical trials have become more targeted and tailored, enabling researchers to identify subgroups of patients who are more likely to respond positively to specific treatments, and eliminating those at risk of adverse drug reaction.
Read more